Skip to main content

Table 2 Mean (SD) of anthropometric and clinical data among IRG and NIRG

From: Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study

 

NIRG

IRG

p

mean

sd

mean

sd

Age, y

66.22

8.93

62.39

9.13

< 0.001

Waist circumference, cm

92.87

7.96

108.58

9.90

< 0.001

Weight, kg

67.91

9.57

87.18

13.7

< 0.001

BMI, kg/m2

25.60

2.30

33.29

3.94

< 0.001

Cholesterol total, mg/dL

160.39

35.30

161.74

36.61

0.72

LDL cholesterol, mg/dL

84.73

28.65

81.75

27.43

0.32

HDL cholesterol, mg/dL

46.78

12.88

44.75

15.80

0.18

Triacylglycerol, mg/dL

142.99

80.49

183.97

125.61

< 0.001

Glycaemia, mg/dL

107.90

37.85

112.78

37.77

0.22

Insulin, mIU/mL

8.19

4.73

15.12

11.88

< 0.001

HOMA

1.11

0.66

1.89

1.20

< 0.001

Systolic blood pressure, mmHg

129.73

20.23

136.85

22.87

< 0.001

Diastolic blood pressure, mmHg

75.27

11.68

81.28

15.55

0.040

CRP, mg/dL

6.00

12.70

7.90

18.60

0.002

Adiponectin, mg/mL

9601.43

6679.80

8149.63

5061.45

0.124

IL-10, pg/mL

21.97

21.62

23.20

22.51

0.499

IL-12, pg/mL

6.88

33.28

4.98

10.70

0.119

IL-1 b, pg/mL

1.11

4.25

2.28

18.27

0.38

IL-6, pg/mL

7.46

13.10

9.04

13.46

0.002

IL-8, pg/mL

4.82

2.78

4.81

2.61

0.964

TNF-a, pg/mL

7.85

5.23

8.49

5.98

0.395

Myristic fatty acid - C14:0 (%)

0.47

0.33

0.60

0.42

0.007

Palmitic fatty acid- C16:0 (%)

24.47

3.50

25.28

3.55

0.07

Palmitoleic fatty acid - C16:1 (%)

1.59

0.74

1.80

0.66

0.001

Estearic fatty acid - C18:0 (%)

12.11

1.67

11.82

1.78

0.18

Oleic fatty acid - C18:1 (%)

20.31

3.80

21.14

3.47

0.07

Linoleic fatty acid - C18:2 (%)

22.85

3.87

22.25

3.38

0.19

α-linolenic fatty acid- C18:3 (%)

0.75

0.33

0.71

0.26

0.322

Eicosatrienoic fatty acid - C20:3 (%)

2.55

0.61

2.57

0.64

0.78

Araquidonic fatty acid -C20:4 (%)

11.42

2.88

10.59

2.61

0.02

Eicosapentaenoic fatty acid - C20:5 (%)

0.74

0.49

0.70

0.29

0.507

Docosapenatenoic fatty acid - C22:5 (%)

0.97

0.27

0.90

0.23

0.02

Docosahexaenoic fatty acid - C22:6 (%)

2.79

1.09

2.53

0.85

0.06

  1. IRG group of patients with insulin resistance, NIRG group of patients non-insulin resistant, BMI body-mass index, CRP C-reactive protein, HDL high-density lipoprotein, HOMA homeostasis model assessment, IL interleukin, LDL low-density lipoprotein, TNF tumor necrosis factor
  2. Data are expressed as mean (standard deviation). P < 0.05 indicate the significant difference between groups